Furthermore, other research showed that the blockade of C5aR1 in combination with the blockade of PD-1 could restore antitumor immune responses, inhibit tumor cell growth, and improve the outcomes of patients with lung cancer (Ajona et al., 2017). This evidence concerns the gene C5AR1 and lung carcinoma.